TFAP4
Basic information
Region (hg38): 16:4257186-4273075
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TFAP4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 11 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 11 | 0 | 1 |
Variants in TFAP4
This is a list of pathogenic ClinVar variants found in the TFAP4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-4258082-C-A | not specified | Uncertain significance (Mar 06, 2023) | ||
16-4258097-G-C | not specified | Uncertain significance (Aug 02, 2023) | ||
16-4258101-A-G | not specified | Uncertain significance (Aug 30, 2022) | ||
16-4258140-T-A | not specified | Uncertain significance (Mar 29, 2022) | ||
16-4258152-G-T | not specified | Uncertain significance (May 30, 2024) | ||
16-4260178-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
16-4260462-C-T | Benign (Oct 17, 2017) | |||
16-4260482-C-A | not specified | Uncertain significance (Apr 15, 2024) | ||
16-4260516-T-G | not specified | Uncertain significance (Jul 14, 2022) | ||
16-4261915-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
16-4262346-G-A | not specified | Uncertain significance (Jun 29, 2023) | ||
16-4262561-T-C | not specified | Uncertain significance (May 26, 2024) | ||
16-4262601-T-C | not specified | Uncertain significance (May 17, 2023) | ||
16-4272701-G-C | not specified | Uncertain significance (Dec 28, 2023) | ||
16-4272707-A-T | not specified | Uncertain significance (Mar 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TFAP4 | protein_coding | protein_coding | ENST00000204517 | 7 | 15890 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.997 | 0.00269 | 104262 | 0 | 2 | 104264 | 0.00000959 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.60 | 152 | 218 | 0.696 | 0.0000153 | 2180 |
Missense in Polyphen | 14 | 52.905 | 0.26463 | 457 | ||
Synonymous | -0.277 | 97 | 93.6 | 1.04 | 0.00000680 | 676 |
Loss of Function | 3.86 | 0 | 17.4 | 0.00 | 9.06e-7 | 182 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000388 | 0.0000388 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000415 | 0.0000415 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription factor that activates both viral and cellular genes by binding to the symmetrical DNA sequence 5'- CAGCTG-3'.;
- Pathway
- Proteoglycans in cancer - Homo sapiens (human)
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 0.08
- rvis_percentile_EVS
- 60.09
Haploinsufficiency Scores
- pHI
- 0.347
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.506
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.797
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tfap4
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; immune system phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;negative regulation of cell population proliferation;positive regulation of apoptotic process;negative regulation of DNA binding;negative regulation by host of viral transcription;positive regulation by host of viral transcription;negative regulation of cyclin-dependent protein serine/threonine kinase activity;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;protein-containing complex assembly;negative regulation of cell cycle arrest;cellular response to dexamethasone stimulus;regulation of mitotic cell cycle phase transition;positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway
- Cellular component
- nucleus;mitochondrion;transcriptional repressor complex
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;transcription coactivator activity;protein binding;protein homodimerization activity;histone deacetylase binding;sequence-specific DNA binding;transcription regulatory region DNA binding;protein heterodimerization activity;E-box binding